Skip to main content

What the FDA labels say about taking them together

Letermovir and modafinil

Letermovir's FDA label of January 14, 2026 names modafinil in its drug interactions section; the modafinil label PlainMeds reads does not name letermovir. The letermovir label: “Co-administration of PREVYMIS and modafinil is not recommended due to potential for loss of efficacy of PREVYMIS.”

Check it at the source: the letermovir FDA label on DailyMed (effective January 14, 2026, Merck Sharp & Dohme LLC); the modafinil FDA label on DailyMed (effective October 16, 2025, Golden State Medical Supply, Inc.).

What does the letermovir label say about modafinil?

Letermovir label, drug interactions

Concomitant Drug Class and/or Clearance Pathway/Drug Name: modafinil; Effect on Concentration ↓ =decrease, ↑ =increase: ↓ letermovir; Clinical Comments: Co-administration of PREVYMIS and modafinil is not recommended due to potential for loss of efficacy of PREVYMIS.

Source: FDA drug label (PREVYMIS), Merck Sharp & Dohme LLC, effective January 14, 2026 (SPL set 1b49df80-be4f-47e0-a0b7-123f3e69395b), via openFDA; the full label on DailyMed

What does the modafinil label say about letermovir?

Modafinil's label (effective October 16, 2025) does not name letermovir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Provigil), NDA020717 (Nuvo Pharms), as published by Golden State Medical Supply, Inc., effective October 16, 2025 (SPL set 3b8d1c32-dac9-50e6-e063-6394a90aa5a5), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Letermovir generic labelers
19Modafinil generic labelers
LetermovirModafinil
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.344 per tablet 200 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?